Stocks in play: Goodbody Health Inc
Announced its rollout plan to introduce blood testing through its existing network of clinics while it continues contracts with new pharmacies. This process includes venous blood draws with an in-clinic phlebotomist and Goodbody have launched its own phlebotomy academy, training staff within its existing clinic network to allow them to offer in clinic health and wellness blood tests. Newly partnered clinics will also have the opportunity to train up to three members of their staff within the phlebotomy training school. The Group continues to bring innovative technologies into its clinics to offer test results, such as cholesterol and diabetes, delivered in minutes. Goodbody Health Inc shares C.GDBY are trading unchanged at $0.07.
Read:
Optimism on the Rise Thanks to New Developments in Oncology in the Fight Against Cancer
Double-Digit Growth in Global Cancer Immunotherapy Market to Drive Advancements Ahead of 2030
Wave of Massive ESG Investments Triggering Major Developments in Mining of Critical Minerals
Investment in New Plant-Based Alternative Meat Products Ramps Up Into 2022
New Treatments Needed as Breast Cancer Was Leading Killer of Female Cancer Patients in 2019